March 2025
1. KIM BC, Pak SJ, Kwon D, Kim WW, et al
   Clinically Significant Central Lymph Node Metastasis is Not Common in Patients with Clinically N0 Papillary Thyroid Carcinoma on Both Ultrasonography and CT.
   Thyroid. 2025 Mar 31. doi: 10.1089/thy.2024.0484.
   

   >> Share

   
   
2. PARK SH, Sugier PE, Asgari Y, Karimi M, et al
   Reproductive Factors, Sex Hormone Levels, and Differentiated Thyroid Cancer Risk: A Mendelian Randomization Study.
   Thyroid. 2025 Mar 26. doi: 10.1089/thy.2024.0548.
   

   >> Share

   
   
3. EINSPIELER H, Hennig B, Reiterits B, Klimpfinger H, et al
   A Retrospective Case-Control Study Examining the Association of Thyroid-Stimulating Hormone Suppression and Vascular Wall Inflammation on [(18)F]FDG-PET/CT.
   Thyroid. 2025 Mar 7. doi: 10.1089/thy.2024.0476.
   

   >> Share

   
   February 2025
4. BELL C, White SL, Tylee T, Dighe M, et al
   Thyroid Nodule Sphericity Metrics Discriminate Benign and Malignant Follicular and Oncocytic Neoplasms.
   Thyroid. 2025 Feb 25. doi: 10.1089/thy.2024.0670.
   

   >> Share

   
   
5. ZHU Q, Liu J, Hu J, Zhang Y, et al
   The Epidemiological Landscape of Thyroid Cancer and Estimates of Overdiagnosis in China: A Population-Based Study.
   Thyroid. 2025 Feb 19. doi: 10.1089/thy.2024.0583.
   

   >> Share

   
   
6. VALERO C, Eagan A, Adilbay D, Matsuura D, et al
   A Clinical Nomogram to Predict Survival Outcomes in Patients with Well-Differentiated Thyroid Cancer.
   Thyroid. 2025 Feb 14. doi: 10.1089/thy.2024.0486.
   

   >> Share

   
   
7. KOTHARI R, Donner JR, Balakrishnan K, Hartman G, et al
   Composition and Priorities of Multidisciplinary Pediatric Thyroid Programs: A Consensus Statement.
   Thyroid. 2025 Feb 14. doi: 10.1089/thy.2024.0496.
   

   >> Share

   
   
8. PRETE A, Torregrossa L, Gambale C, Ciampi R, et al
   The Usefulness of the International Grading System in the Management of Sporadic Medullary Thyroid Carcinoma.
   Thyroid. 2025 Feb 11. doi: 10.1089/thy.2024.0444.
   

   >> Share

   
   January 2025
9. RAO S, Frates MC, Benson CB, Cherella CE, et al
   Utility of Ultrasound Surveillance for Thyroid Cancer in Children.
   Thyroid. 2025 Jan 31. doi: 10.1089/thy.2024.0624.
   

   >> Share

   
   
10. NACHUM S, Tondi Resta I, Baloch Z, Mandel SJ, et al
    Thyroid Nodules with Indeterminate Cytology and Negative Molecular Profile: Prevalence of Malignancy and Practice Paradigms for Surveillance.
    Thyroid. 2025 Jan 28. doi: 10.1089/thy.2024.0455.
    

    >> Share

    
    
11. BALLAL S, Yadav MP, Satapathy S, Roesch F, et al
    Long-Term Outcomes in Radioiodine-Resistant Follicular Cell-Derived Thyroid Cancers Treated with [(177)Lu]Lu-DOTAGA.FAPi Dimer Therapy.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0229.
    

    >> Share

    
    
12. KHAN E, Hylton H, Rajan N, Bouley SJ, et al
    Proteomic Profiling of Medullary Thyroid Cancer Identifies CAPN1 as a Key Regulator of NF1 and RET Fueled Growth.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0102.
    

    >> Share

    
    
13. JEONG SY, Baek SM, Shin S, Son JM, et al
    Radiofrequency Ablation of Low-Risk Papillary Thyroid Microcarcinoma: A Retrospective Cohort Study Including Patients with More than 10 Years of Follow-up.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0535.
    

    >> Share

    
    
14. BYUN H, Lee HS, Song YS, Park YJ, et al
    Transcriptome of Anaplastic Thyroid Cancer Reveals Two Molecular Subtypes with Distinct Tumor Microenvironment and Prognosis.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0266.
    

    >> Share

    
    
15. PAPACHRISTOS A, Zhou L, Sheen A, Sywak M, et al
    Tumor-Infiltrating Lymphocytes Assessed Using the International TILs Working Group System Are Not Prognostic in Medullary Thyroid Cancer.
    Thyroid. 2025 Jan 27. doi: 10.1089/thy.2024.0595.
    

    >> Share

    
    
16. FUNG MHM, Tang C, Kwok GW, Chan TH, et al
    High Rates of Unnecessary Surgery for Indeterminate Thyroid Nodules in the Absence of Molecular Test and the Cost-Effectiveness of Utilizing Molecular Test in an Asian Population: A Decision Analysis.
    Thyroid. 2025 Jan 21. doi: 10.1089/thy.2024.0436.
    

    >> Share

    
    
17. BAXTER SM, Lund LC, Andersen JH, Brix TH, et al
    Glucagon-Like Peptide 1 Receptor Agonists and Risk of Thyroid Cancer: An International Multisite Cohort Study.
    Thyroid. 2025 Jan 8. doi: 10.1089/thy.2024.0387.
    

    >> Share

    
    
18. SCHOLFIELD DW, Xu B, Levyn H, Eagan A, et al
    High-Grade Follicular Cell-Derived Non-Anaplastic Thyroid Carcinoma: Correlating Extent of Invasion and Mutation Profile with Oncologic Outcome.
    Thyroid. 2025 Jan 6. doi: 10.1089/thy.2024.0499.
    

    >> Share

    
    December 2024
19. QIANG JK, Sutradhar R, Everett K, Eskander A, et al
    Association Between Serum Thyrotropin and Cancer Recurrence in Differentiated Thyroid Cancer: A Population-Based Retrospective Cohort Study.
    Thyroid. 2024 Dec 26. doi: 10.1089/thy.2024.0330.
    

    >> Share

    
    
20. JAGER EC, Metman MJH, Timmenga IAC, Zandee WT, et al
    Trends in the Incidence, Organization of Care, and Surgical Treatment of Medullary Thyroid Cancer: A Population-Based Study.
    Thyroid. 2024 Dec 20. doi: 10.1089/thy.2024.0433.
    

    >> Share

    
    
21. KUNSTREICH M, Ronckers CM, Lorenz K, Wolf SH, et al
    Subsequent Thyroid Carcinomas in Children and Adolescents Registered in the German MET Consortium (1997-2023).
    Thyroid. 2024 Dec 19. doi: 10.1089/thy.2024.0312.
    

    >> Share

    
    
22. DUENAS JP, Buitrago-Gomez N, Rahal A, Steck JH, et al
    Radiofrequency Ablation for Solitary Autonomously Functioning Thyroid Nodules: Multicenter Study from Latin America.
    Thyroid. 2024 Dec 19. doi: 10.1089/thy.2024.0338.
    

    >> Share

    
    
23. MOON SY, Son M, Cho JH, Kim HI, et al
    Association Between Metabolic Dysfunction-Associated Steatotic Liver Disease and Thyroid Cancer.
    Thyroid. 2024 Dec 18. doi: 10.1089/thy.2024.0522.
    

    >> Share

    
    
24. ERDOGAN MF, Bahcecioglu AB, Avci Merdin F, Elhan AH, et al
    Changes in the Volume and Diameter of Benign Thyroid Nodules: A 10-Year Follow-Up Study.
    Thyroid. 2024 Dec 18. doi: 10.1089/thy.2024.0405.
    

    >> Share

    
    
25. MOON HH, Baek JH, Chung SR, Choi YJ, et al
    Preliminary Report Examining Efficacy and Safety of Radiofrequency Ablation for the Treatment of Skin-Involving Recurrent Thyroid Cancer.
    Thyroid. 2024 Dec 17. doi: 10.1089/thy.2024.0339.
    

    >> Share

    
    
26. HU G, Xue J, Yu J, Dou Q, et al
    High Prevalence of TBC1D12 5'UTR Mutations in Anaplastic Thyroid Cancer.
    Thyroid. 2024 Dec 16. doi: 10.1089/thy.2024.0345.
    

    >> Share

    
    
27. HAMIDI S, Yedururi S, Hu MI, Busaidy NL, et al
    Efficacy and Safety of Selective RET Inhibitors in Patients with Advanced Hereditary Medullary Thyroid Carcinoma.
    Thyroid. 2024 Dec 4. doi: 10.1089/thy.2024.0495.
    

    >> Share

    
    
28. JIN X, Broome DT, Lew M, Heider A, et al
    Performance of Afirma Genomic Sequencing Classifier in Binary Subcategories of Atypia of Undetermined Significance Thyroid Nodules: Single Versus Repeat Diagnosis.
    Thyroid. 2024 Dec 4. doi: 10.1089/thy.2024.0277.
    

    >> Share

    
    November 2024
29. FERNANDES-TAYLOR S, Bowles EJA, Venkatesh M, Doud R, et al
    Differential Ultrasound Rates Mirror Sex Disparities in Thyroid Cancer.
    Thyroid. 2024 Nov 28. doi: 10.1089/thy.2024.0344.
    

    >> Share

    
    
30. KUO TC, Chen KY, Hu HW, Jhuang JY, et al
    Surgical and Pathological Challenges in Thyroidectomy after Thermal Ablation of Thyroid Nodules.
    Thyroid. 2024 Nov 22. doi: 10.1089/thy.2024.0281.
    

    >> Share

    
    
31. VOHRA V, Yesantharao LV, Stemme R, Seal SM, et al
    Association Between Environmental Air Pollution and Thyroid Cancer and Nodules: A Systematic Review.
    Thyroid. 2024 Nov 18. doi: 10.1089/thy.2024.0317.
    

    >> Share

    
    
32. HUSTON-PATERSON HH, Mao YV, Tseng CH, Kim J, et al
    The Relationship Between Hospital Safety-Net Burden on Outcomes for High-Volume Thyroid Cancer Surgeons.
    Thyroid. 2024 Nov 11. doi: 10.1089/thy.2024.0268.
    

    >> Share

    
    
33. JASIM S, Golding A, Bimston D, Alshalalfa M, et al
    Cytologic and Molecular Assessment of Isthmus Thyroid Nodules and Carcinomas.
    Thyroid. 2024 Nov 11. doi: 10.1089/thy.2024.0254.
    

    >> Share

    
    October 2024
34. NGUYEN TNA, Nguyen VPT, Kurohama H, Akazawa Y, et al
    Association Between Gross Features and Coexistence of BRAF(V600E) and TERT Promoter Mutations in Papillary Thyroid Carcinomas: A Combined Analysis Incorporating Clinicopathologic Features.
    Thyroid. 2024 Oct 31. doi: 10.1089/thy.2024.0310.
    

    >> Share

    
    
35. KUHLEN M, Wellbrock M, Kunstreich M, Trubenbach C, et al
    Incidence and Temporal Patterns of Differentiated Thyroid Carcinoma in Children and Adolescents in Germany: A Pooled Analysis Based on Data from the German Malignant Endocrine Tumor Registry and the German Childhood Cancer Registry.
    Thyroid. 2024 Oct 30. doi: 10.1089/thy.2024.0534.
    

    >> Share

    
    
36. PILZ MJ, Seyringer S, Singer S, Ioannidis G, et al
    The Cancer-Specific Health Economic Measure QLU-C10D is Valid and Responsive for Assessing Health Utility in Patients with Thyroid Cancer.
    Thyroid. 2024 Oct 30. doi: 10.1089/thy.2024.0396.
    

    >> Share

    
    
37. GU X, Zhu P, Zhang H, Wang W, et al
    A Qualitative Thematic Analysis Exploring Chinese Young Adults' Experiences in Decision Making on the Management of Low-Risk Papillary Thyroid Cancer.
    Thyroid. 2024 Oct 17. doi: 10.1089/thy.2024.0210.
    

    >> Share

    
    
38. ELDEIRY LS, Lawrence JE, Taneja C, Margulies D, et al
    American Thyroid Association Policy Statement: Impact of Changes in Fine Needle Aspiration Biopsy Reimbursement on Clinical Care of Patients with Thyroid Nodules in the United States.
    Thyroid. 2024 Oct 16. doi: 10.1089/thy.2024.0442.
    

    >> Share

    
    
39. ASHTON J, Morrison S, Erkanli A, Wildman-Tobriner B, et al
    Assessment of the Diagnostic Performance of a Commercially Available Artificial Intelligence Algorithm for Risk Stratification of Thyroid Nodules on Ultrasound.
    Thyroid. 2024 Oct 15. doi: 10.1089/thy.2024.0410.
    

    >> Share

    
    
40. MATSUMOTO Y, Kobashi Y, Yamaya Y, Sekino M, et al
    Clinicopathological Findings of 220 Pediatric, Adolescent, and Young Adult Patients with Thyroid Cancer in Fukushima Medical University Hospital.
    Thyroid. 2024 Oct 14. doi: 10.1089/thy.2024.0226.
    

    >> Share

    
    September 2024
41. KROPINSKA A, Ledwon A, Paliczka Cieslik E, Olczyk T, et al
    Changing Clinical Presentation of Pediatric Differentiated Thyroid Cancer in Poland: A Retrospective Cohort Study Spanning 45 Years.
    Thyroid. 2024 Sep 25. doi: 10.1089/thy.2024.0109.
    

    >> Share

    
    
42. KIM MJ, Won H, Kim WB, Lee EK, et al
    Comparison of Patient Reported Outcomes between Active surveillance and Immediate Lobectomy in Patients with Low-risk Papillary Thyroid Microcarcinoma: Initial Findings from the KoMPASS cohort.
    Thyroid. 2024 Sep 17. doi: 10.1089/thy.2024.0264.
    

    >> Share

    
    
43. ATTIA A, Touma E, Lussey-Lepoutre C, Ghander C, et al
    Consideration of Early Dynamic Risk Stratification to Guide Discharge from Oncologic Follow-up in Patients with Differentiated Thyroid Cancer.
    Thyroid. 2024 Sep 17. doi: 10.1089/thy.2024.0119.
    

    >> Share

    
    
44. MASTNIKOVA K, Bulanova Pekova B, Kuklikova V, Vaclavikova E, et al
    DICER1 Variants in Pediatric and Young Adult Thyroid Nodules.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0188.
    

    >> Share

    
    
45. VAN DE BERG DJ, Rodriguez Schaap PM, Jamaludin FS, van Santen HM, et al
    The Definition of Recurrence of Differentiated Thyroid Cancer: A Systematic Review of the Literature.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0271.
    

    >> Share

    
    
46. SONG Z, Wu C, Kasmirski J, Gillis A, et al
    Incidental Thyroid Nodules on Computed Tomography: A Systematic Review and Meta-analysis Examining Prevalence, Follow-up and Risk of Malignancy.
    Thyroid. 2024 Sep 16. doi: 10.1089/thy.2024.0313.
    

    >> Share

    
    
47. LEE JY, Lee MK, Lee JH, Kim K, et al
    Cancer risks of patients with Graves' disease who received antithyroid drugs as initial treatment: A nationwide population-based analysis.
    Thyroid. 2024 Sep 3. doi: 10.1089/thy.2024.0178.
    

    >> Share

    
    August 2024
48. LEE JY, Na DG, Sim JS, Sung JY, et al
    A Prospective Clinical Trial of Radiofrequency Ablation in Patients with Low-Risk Unifocal Papillary Thyroid Microcarcinoma favoring Active Surveillance over Surgery.
    Thyroid. 2024 Aug 30. doi: 10.1089/thy.2024.0098.
    

    >> Share

    
    
49. WANG Z, Yao Q, Bao L, Chang H, et al
    Clinicopathological Features of CCDC6-RET and NCOA4-RET Fusions in Thyroid Cancer: A Single-center Retrospective Cohort Study in a Chinese Population.
    Thyroid. 2024 Aug 30. doi: 10.1089/thy.2024.0151.
    

    >> Share

    
    
50. PRINZI A, van Velsen EFS, Belfiore A, Frasca F, et al
    Brain Metastasis in Differentiated Thyroid Cancer: Clinical Presentation, Diagnosis and Management.
    Thyroid. 2024 Aug 20. doi: 10.1089/thy.2024.0240.
    

    >> Share

    
    
51. WEN S, Wu Y, Wang JY, Ni Z, et al
    BRAFV600E/ p-ERK/ p-DRP1(Ser616) Promotes Tumor Progression and Reprogramming of Glucose Metabolism in Papillary Thyroid Cancer.
    Thyroid. 2024 Aug 20. doi: 10.1089/thy.2023.0700.
    

    >> Share

    
    
52. RICARTE-FILHO JC, Reichenberger ER, Hinkle K, Isaza A, et al
    TG-IGF1R: A Novel Receptor Tyrosine Kinase Fusion Oncogene in Pediatric Thyroid Cancer.
    Thyroid. 2024 Aug 6. doi: 10.1089/thy.2024.0224.
    

    >> Share

    
    July 2024
53. KHENG M, Manzella A, Chao JC, Laird AM, et al
    Reoperation Rates after Initial Thyroid Lobectomy for Patients with Thyroid Cancer: A National Cohort Study.
    Thyroid. 2024 Jul 25. doi: 10.1089/thy.2024.0128.
    

    >> Share

    
    
54. GOLDFARB M
    In the Heat of the Moment: Thermal Ablation for 'All Things Thyroid'.
    Thyroid. 2024 Jul 23. doi: 10.1089/thy.2024.0391.
    

    >> Share

    
    
55. PARK SI, Baek JH, Lee DH, Chung SR, et al
    Radiofrequency Ablation for the Treatment of Benign Thyroid nodules: 10-Year Experience.
    Thyroid. 2024 Jul 23. doi: 10.1089/thy.2024.0082.
    

    >> Share

    
    
56. SCAPPATICCIO L, Ferrazzano P, Di Martino N, Negro R, et al
    Prevalence and Management of Complications of Percutaneous Ethanol Injection for Cystic Thyroid Nodules: A Systematic Review of Literature and Meta-analysis.
    Thyroid. 2024 Jul 20. doi: 10.1089/thy.2024.0241.
    

    >> Share

    
    
57. ANTUNEZ AG, Saucke MC, Bushaw KJ, Chiu AS, et al
    Surgeon preference for maximizing medical care is associated with recommending more extensive surgery for low-risk thyroid cancer.
    Thyroid. 2024 Jul 20. doi: 10.1089/thy.2024.0170.
    

    >> Share

    
    
58. SABBAGH MF, Janovitz T, Dias-Santagata D, Siegmund SE, et al
    FGFR Alterations in Thyroid Carcinoma: A Novel Class of Primary Drivers with Significant Therapeutic Implications and Secondary Molecular Events Potentially Mediating Resistance in Thyroid Malignancy.
    Thyroid. 2024 Jul 14. doi: 10.1089/thy.2024.0216.
    

    >> Share

    
    
59. SZABO YAMASHITA T, Williams-Perez S, Ehsan S, Mulder MB, et al
    The Multi-institutional Medullary Thyroid Cancer Collaborative Registry (MTCCoRe): Can a rare tumor registry accurately represent the real-world patient population?
    Thyroid. 2024 Jul 10. doi: 10.1089/thy.2024.0239.
    

    >> Share

    
    
60. MATRONE A, Kroiss M, Gild ML, Hamidi S, et al
    Erectile dysfunction in patients treated with selpercatinib for RET altered thyroid cancer.
    Thyroid. 2024 Jul 10. doi: 10.1089/thy.2024.0129.
    

    >> Share

    
    June 2024
61. PERAMPALAM S, Wu K, Gild ML, Tacon L, et al
    Association between lymphocytic thyroiditis and papillary thyroid cancer harboring mutant BRAF: a systematic review and meta-analysis.
    Thyroid. 2024 Jun 28. doi: 10.1089/thy.2024.0142.
    

    >> Share

    
    
62. DEVON K, Tinckam K, Humar A, Madani A, et al
    Successful Deceased Donor Parathyroid Allotransplantation: A Novel Approach in a Patient with Severe Refractory Hypoparathyroidism after Thyroidectomy for Thyroid Cancer.
    Thyroid. 2024 Jun 26. doi: 10.1089/thy.2024.0115.
    

    >> Share

    
    
63. DIONISIO T, Mauri G
    Ultrasound Evaluation of Ablated Thyroid Nodules: An Emerging Problem.
    Thyroid. 2024 Jun 25. doi: 10.1089/thy.2024.0244.
    

    >> Share

    
    
64. KOTWAL A, Vance K, Hajric K, Yuil-Valdes A, et al
    Characterization of immune infiltrate along the leading edge of differentiated thyroid cancer.
    Thyroid. 2024 Jun 25. doi: 10.1089/thy.2024.0072.
    

    >> Share

    
    
65. GINZBERG SP, Sharpe J, Passman JE, Amjad W, et al
    Revisiting the Relationship between Tumor Size and Risk in Well-Differentiated Thyroid Cancer.
    Thyroid. 2024 Jun 15. doi: 10.1089/thy.2023.0327.
    

    >> Share

    
    
66. LEE Y, Alam MR, Park H, Yim K, et al
    Improved diagnostic accuracy of thyroid fine-needle aspiration cytology with artificial intelligence technology.
    Thyroid. 2024 Jun 14. doi: 10.1089/thy.2023.0384.
    

    >> Share

    
    May 2024
67. SCHNEIDER AB, Mihailescu DV
    Radiation Exposure and Benign Thyroid Nodules.
    Thyroid. 2024 May 27. doi: 10.1089/thy.2024.0279.
    

    >> Share

    
    
68. KIM CA, Baek S, Yoo J, Chung SR, et al
    Tumor Growth Kinetics Based on Initial Tumor Volume Doubling Time in Active Surveillance of Low-Risk Papillary Thyroid Carcinoma.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2024.0054.
    

    >> Share

    
    
69. CHEN D, Carr G, Worden FP, Veenstra CM, et al
    Survival Prognostication in Patients with Differentiated Thyroid Cancer and Distant Metastases: A SEER Population-Based Study.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2023.0709.
    

    >> Share

    
    
70. PITOIA F, Abelleira E, Roman-Gonzalez A, Danilovic DLS, et al
    Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2024.0090.
    

    >> Share

    
    
71. CAHOON EK, Grimm E, Mabuchi K, Mai JZ, et al
    Prevalence of thyroid nodules in residents of Ukraine exposed as children or adolescents to iodine-131 from the Chornobyl accident.
    Thyroid. 2024 May 17. doi: 10.1089/thy.2023.0654.
    

    >> Share

    
    
72. BIONDI B
    TSH Suppression in Differentiated Thyroid Cancer Patients. Still More Questions than Answers after 30 Years.
    Thyroid. 2024 May 14. doi: 10.1089/thy.2024.0232.
    

    >> Share

    
    
73. GUBBI S, Al-Jundi M, Foerster P, Cardenas S, et al
    The Effect of Thyrotropin Suppression on Survival Outcomes in Patients with Differentiated Thyroid Cancer: A Systematic Review and Meta-analysis.
    Thyroid. 2024 May 8. doi: 10.1089/thy.2023.0711.
    

    >> Share

    
    
74. MACHENS A, Lorenz K, Weber F, Dralle H, et al
    Anatomic Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid Cancer.
    Thyroid. 2024 May 8. doi: 10.1089/thy.2024.0076.
    

    >> Share

    
    April 2024
75. CHOI YS, Jeon MJ, Doolittle WKL, Song DE, et al
    Macrophage-induced carboxypeptidase A4 promotes the progression of anaplastic thyroid cancer.
    Thyroid. 2024 Apr 26. doi: 10.1089/thy.2023.0427.
    

    >> Share

    
    
76. ZHOU Y, Yang F, Zhou H, Lv S, et al
    Alginate/carboxymethyl chitosan core-shell microspheres co-loaded with docetaxel/doxorubicin reverse chemotherapy resistance in anaplastic thyroid carcinoma.
    Thyroid. 2024 Apr 25. doi: 10.1089/thy.2024.0023.
    

    >> Share

    
    
77. HIDALGO-ALVAREZ J, Bianco AC
    A Scholarly Dialog on Recent Trends in NIH Funding for the Thyroid Field.
    Thyroid. 2024 Apr 25. doi: 10.1089/thy.2024.0084.
    

    >> Share

    
    
78. TAHARA M, Takami H, Ito Y, Okamoto T, et al
    A Prospective Cohort Study Exploring the Effect of Lenvatinib Planned Drug Holidays in Treatment of Differentiated Thyroid Cancer.
    Thyroid. 2024 Apr 17. doi: 10.1089/thy.2023.0553.
    

    >> Share

    
    March 2024
79. WINTER J, Axelsson E, Bjorkhem-Bergman L, Ihre Lundgren C, et al
    Five-year follow-up of health-related quality of life in differentiated thyroid cancer patients treated with total thyroidectomy and radioiodine in Sweden: a nationwide prospective cohort study.
    Thyroid. 2024 Mar 25. doi: 10.1089/thy.2023.0691.
    

    >> Share

    
    
80. SAWKA AM, Ghai S, Rotstein L, Irish JC, et al
    Decision Regret Following the Choice of Surgery or Active Surveillance for Small, Low-Risk Papillary Thyroid Cancer: A Prospective Cohort Study.
    Thyroid. 2024 Mar 13. doi: 10.1089/thy.2023.0634.
    

    >> Share

    
    
81. STILLMAN M, Kuo EJ, Liou R, Almuqate A, et al
    Molecular Testing for Bethesda III Thyroid nodules: Trends in Implementation, Cytopathology Call Rates, Surgery Rates, and Malignancy Yield at a Single Institution.
    Thyroid. 2024 Mar 12. doi: 10.1089/thy.2023.0664.
    

    >> Share

    
    February 2024
82. JIANG YJ, Xia Y, Hu Y, Han Z, et al
    Identification of P21 (CDKN1A) Activated Kinase 4 as a susceptibility gene for Familial Non-medullary Thyroid Carcinoma.
    Thyroid. 2024 Feb 27. doi: 10.1089/thy.2023.0564.
    

    >> Share

    
    
83. SFREDDO HJ, Koh ES, Zhao K, Swartzwelder CE, et al
    RAS-Mutated Cytologically Indeterminate Thyroid Nodules: Prevalence of Malignancy and Behavior Under Active Surveillance.
    Thyroid. 2024 Feb 26. doi: 10.1089/thy.2023.0544.
    

    >> Share

    
    
84. FERNANDEZ-VELASCO P, Perez Lopez P, Torres B, Delgado E, et al
    Clinical evaluation of an Artificial Intelligence-based decision support system for the diagnosis and ACR TI-RADS classification of thyroid nodules.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2023.0603.
    

    >> Share

    
    
85. HAMPTON J, Alam A, Zdenkowski N, Rowe C, et al
    Fear of Cancer Recurrence in Differentiated Thyroid Cancer Survivors - A Systematic Review.
    Thyroid. 2024 Feb 18. doi: 10.1089/thy.2023.0642.
    

    >> Share

    
    
86. PASCHKE R
    Why did the rapid increase of reflex molecular testing of indeterminate FNA cytologies in the USA not impact thyroidectomy rates? What is the lesson to be learned?
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2024.0042.
    

    >> Share

    
    
87. ESPINOSA DE YCAZA AE, Brito JP, McCoy R, Shao H, et al
    GLP-1 receptor agonists and thyroid cancer: a narrative review.
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0530.
    

    >> Share

    
    
88. TAHARA M, Kiyota N, Imai H, Takahashi S, et al
    A phase II study of encorafenib in combination with binimetinib in patients with metastatic BRAF-mutated thyroid cancer in Japan.
    Thyroid. 2024 Feb 12. doi: 10.1089/thy.2023.0547.
    

    >> Share

    
    January 2024
89. BROCK P, Liyanarachchi S, Nieminen TT, Chan C, et al
    CHEK2 founder variants and thyroid cancer risk.
    Thyroid. 2024 Jan 27. doi: 10.1089/thy.2023.0529.
    

    >> Share

    
    
90. LIU CH, Zhao H, Lu Y, Xia Y, et al
    A long-term study comparing the quality of life and psychological status of patients with highly suspicious thyroid nodules
    Thyroid. 2024 Jan 25. doi: 10.1089/thy.2023.0478.
    

    >> Share

    
    
91. HUANG Y, Chan SJ, Wright JD, Kuo JH, et al
    Does the Adoption of Molecular Testing Cause Decreased Thyroidectomy Rates in a National Cohort? A Quasi-Experimental Study of High- Vs. Low-Adoption States.
    Thyroid. 2024 Jan 22. doi: 10.1089/thy.2023.0651.
    

    >> Share

    
    
92. YANG F, Yang M, Liu Y, Zhou C, et al
    PDLIM7 promotes tumor metastasis in papillary thyroid carcinoma via stabilizing FAK protein.
    Thyroid. 2024 Jan 20. doi: 10.1089/thy.2023.0497.
    

    >> Share

    
    
93. HAMIDI S, Iyer P, Dadu R, Gule-Monroe M, et al
    Checkpoint Inhibition in Addition to Dabrafenib/Trametinib for BRAF(V600E) Mutated Anaplastic Thyroid Carcinoma.
    Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0573.
    

    >> Share

    
    
94. MIYAUCHI A
    Response to Xiang J. and Zhang H. re: "Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status".
    Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0697.
    

    >> Share

    
    
95. XIANG J, Zhang H
    Letter to the Editor: Active Surveillance Outcomes of Patients with Low-Risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
    Thyroid. 2024 Jan 16. doi: 10.1089/thy.2023.0605.
    

    >> Share

    
    
96. 
    Correction to: Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network by Jannin et al. Thyroid 2023;33(10):1190-1200; doi: 10.1089/thy.2023.0164.
    Thyroid. 2024;34:140.
    

    >> Share

    
    December 2023
97. TRAN TV, Schonfeld SJ, Pasqual E, Haymart MR, et al
    All-cause and cause-specific mortality among low-risk differentiated thyroid cancer survivors in the United States.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0449.
    

    >> Share

    
    
98. PARK SK, Ryoo JH, Kim MH, Jung JY, et al
    Association between eight autoimmune diseases and thyroid cancer: A Nationwide Cohort Study.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0353.
    

    >> Share

    
    
99. BERNARDI S, Rosolen V, Barbone F, Borgato S, et al
    Clinical outcomes of thermal ablation retreatment of benign thyroid nodules: A multicenter study from the Italian minimally-invasive treatments of the thyroid group.
    Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0501.
    

    >> Share

    
    
100. SHIRAI YT, Hoshi N, Ward JM, Liu H, et al
     Establishment and characterization of amitrole-induced mouse thyroid adenomatous nodule-derived cell lines.
     Thyroid. 2023 Dec 27. doi: 10.1089/thy.2023.0341.
     

     >> Share

     
     
101. POMA AM, Macerola E, Ghossein R MD, Tallini G, et al
     Prevalence of differentiated high-grade thyroid carcinoma among well-differentiated tumors: a systematic review and meta-analysis.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0350.
     

     >> Share

     
     
102. TAYLOR SR, Chiu AS, Hoxha I, Saucke MC, et al
     Assessing Fear of Thyroid Cancer in the General U.S. Population: A Cross-Sectional Study.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0479.
     

     >> Share

     
     
103. CHENG SY, Kimura T, Doolittle WKL, Kruhlak M, et al
     Inhibition of MEK signaling attenuates cancer stem cell activity in anaplastic thyroid cancer.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0521.
     

     >> Share

     
     
104. HUSTON-PATERSON HH, Mao YV, Tseng CH, Kim J, et al
     Rural-urban Disparities in the Continuum of Thyroid Cancer Care: Analysis of 92,794 cases.
     Thyroid. 2023 Dec 19. doi: 10.1089/thy.2023.0357.
     

     >> Share

     
     
105. FEI-ZHANG D, Verma R, Arimoto R, Lawrence AS, et al
     Social Vulnerability Association with Thyroid Cancer Disparities in the United States.
     Thyroid. 2023 Dec 9. doi: 10.1089/thy.2023.0370.
     

     >> Share

     
     
106. HURST ZA, Liyanarachchi S, Brock P, He H, et al
     Presumed Pathogenic Germline and Somatic Variants in African American Thyroid Cancer.
     Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0487.
     

     >> Share

     
     
107. CAPDEVILA J, Krajewska J, Hernando J, Robinson B, et al
     Increased progression-free survival with cabozantinib versus placebo in patients with radioiodine-refractory differentiated thyroid cancer irrespective of prior VEGFR-targeted therapy and tumor histology: a subgroup analysis of the COSMIC-311 study.
     Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0463.
     

     >> Share

     
     
108. BROCK P, Sevigny M, Liyanarachchi S, Comiskey DF Jr, et al
     PDPR gene variants predisposing to papillary thyroid cancer.
     Thyroid. 2023 Dec 7. doi: 10.1089/thy.2023.0560.
     

     >> Share

     
     
109. CENSI S, Galuppini F, Clausi C, Battheu F, et al
     Tumor grade and molecular characteristics associated with survival in sporadic medullary thyroid carcinoma.
     Thyroid. 2023 Dec 4. doi: 10.1089/thy.2023.0482.
     

     >> Share

     
     
110. CAVALLO AC, Pitoia F, Roberti J, Brenzoni P, et al
     Optimizing Diagnostic Accuracy of Fine Needle Aspiration Biopsy Calcitonin Measurements in Detecting Medullary Thyroid Carcinoma.
     Thyroid. 2023 Dec 4. doi: 10.1089/thy.2023.0313.
     

     >> Share

     
     November 2023
111. PARK SJ, Kim M, Jeong S, Park YJ, et al
     Association Between Antibiotic Exposure and Thyroid Cancer: A Nationwide Cohort Study in South Korea.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0235.
     

     >> Share

     
     
112. DE KOSTER EJ, Morreau H, Bleumink GS, van Engen-van Grunsven I, et al
     Molecular diagnostics and [18F]FDG-PET/CT in indeterminate thyroid nodules: complementing techniques or waste of valuable resources?
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0337.
     

     >> Share

     
     
113. SUBBIAH V, Hu MI, Mansfield AS, Taylor MH, et al
     Pralsetinib in Patients with Advanced/metastatic RET-altered Thyroid Cancer: Updated Efficacy and Safety Data from the ARROW Study.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0363.
     

     >> Share

     
     
114. CAMPBELL DJ, Estephan LE, Sina E, Mastrolonardo EV, et al
     Evaluating ChatGPT responses on thyroid nodules for patient education.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0491.
     

     >> Share

     
     
115. ASSAAD S, Dov D, Park C, Davis R, et al
     A preliminary study comparing the performance of thyroid molecular tests to a deep learning algorithm in predicting malignancy in indeterminate thyroid fine needle aspiration biopsies.
     Thyroid. 2023 Nov 27. doi: 10.1089/thy.2023.0054.
     

     >> Share

     
     
116. KENNEDY E, Zhang C, Qadadha Y, Cheng CF, et al
     Rates of Detecting Thyroid Nodules Recommended for Biopsy with Ultrasound: Are All Indications Equal?
     Thyroid. 2023 Nov 19. doi: 10.1089/thy.2023.0234.
     

     >> Share

     
     
117. TARASOVA VD, Tsai J, Masannat J, Hernandez-Prera J, et al
     Characterization of the thyroid cancer genomic landscape by plasma-based circulating tumor DNA next-generation sequencing.
     Thyroid. 2023 Nov 14. doi: 10.1089/thy.2023.0204.
     

     >> Share

     
     
118. LI X, Peng C, Liu Y, Hu Y, et al
     Modified ACR TI-RADS and Modified AI TI-RADS for Thyroid Nodules: A Multicenter Retrospective Study.
     Thyroid. 2023 Nov 11. doi: 10.1089/thy.2023.0429.
     

     >> Share

     
     
119. LEE I, Grice JV, Ji X, Chen Q, et al
     A Pilot Nonrandomized Controlled Trial Examining the Use of Artificial Tears on the Radioactivity of Tears after Radioactive Iodine Treatment for Thyroid Cancer.
     Thyroid. 2023 Nov 2. doi: 10.1089/thy.2023.0338.
     

     >> Share

     
     
120. TORO-TOBON D, Morris JC 3rd, Hilger CR, Peskey C, et al
     Clinical outcomes of radioactive iodine redifferentiation therapy in previously iodine refractory differentiated thyroid cancers.
     Thyroid. 2023 Nov 2. doi: 10.1089/thy.2023.0456.
     

     >> Share

     
     
121. MOOG S, Lamartina L, Bani MA, Al Ghuzlan A, et al
     Alkylating Agent-Induced High Tumor Mutational Burden in Medullary Thyroid Cancer and Response to Immune Checkpoint Inhibitors: Two Case Reports.
     Thyroid. 2023;33:1368-1373.
     

     >> Share

     
     October 2023
122. LI X, Li Y, Yan L, Xiao J, et al
     Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer after Radiofrequency Ablation: a 5-Year Retrospective Cohort Study.
     Thyroid. 2023 Oct 26. doi: 10.1089/thy.2023.0415.
     

     >> Share

     
     
123. BACH K, Ansari P, Ansari H, Mott NM, et al
     Health-related Quality of Life in Patients with Low-risk Differentiated Thyroid Cancer: A Systematic Review Examining the Extent of Thyroidectomy.
     Thyroid. 2023 Oct 20. doi: 10.1089/thy.2023.0328.
     

     >> Share

     
     
124. XU B, Viswanathan K, Ahadi MS, Ahmadi S, et al
     Association of the Genomic Profile of Medullary Thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
     Thyroid. 2023 Oct 16. doi: 10.1089/thy.2023.0279.
     

     >> Share

     
     
125. JANNIN A, Giudici F, de la Fouchardiere C, Al Ghuzlan A, et al
     Factors Associated with Survival in Anaplastic Thyroid Carcinoma: A Multicenter Study from the ENDOCAN-TUTHYREF Network.
     Thyroid. 2023;33:1190-1200.
     

     >> Share

     
     September 2023
126. PAPADOPOULOU A, Asvold BO, Burgess S, Kus A, et al
     Height, autoimmune thyroid disease and thyroid cancer: a Mendelian randomisation study.
     Thyroid. 2023 Sep 29. doi: 10.1089/thy.2023.0272.
     

     >> Share

     
     
127. STEWARDSON P, Eszlinger M, Wu J, Khalil M, et al
     Prospective Validation of ThyroSPEC Molecular Testing of Indeterminate Thyroid Nodule Cytology Following Diagnostic Pathway Optimization.
     Thyroid. 2023 Sep 24. doi: 10.1089/thy.2023.0255.
     

     >> Share

     
     
128. XIAO X, Chen M, Sang Y, Xue J, et al
     Methylation-mediated silencing of ATF3 promotes thyroid cancer progression by regulating prognostic genes in the MAPK and PI3K/AKT pathways.
     Thyroid. 2023 Sep 24. doi: 10.1089/thy.2023.0157.
     

     >> Share

     
     
129. GUPTA M, Misariu AM, Saydy N, Nichols A, et al
     A Multicentre Retrospective Study of Anaplastic Thyroid Cancer in the Era of Targeted Therapy in a Public Health Care System: Canada's Experience.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0088.
     

     >> Share

     
     
130. DE LEO S, D'Elia S, Grani G, Dondi F, et al
     A Prospective, Multicenter Study Examining the Relationship between Thyroid Cancer Treatment Outcomes and the Presence of Autoimmune Thyroiditis.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0052.
     

     >> Share

     
     
131. BALAKIROUCHENANE D, Seban R, Groussin L, Puszkiel A, et al
     Pharmacokinetics/Pharmacodynamics of dabrafenib and trametinib for redifferentiation and treatment of radioactive-iodine-resistant mutated advanced differentiated thyroid cancer.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0228.
     

     >> Share

     
     
132. BIONDI B MD, Pucci M, Pontieri G, Formisano P, et al
     PRELIMINARY RESULTS OF A DOUBLE-BLIND RANDOMIZED CONTROLLED TRIAL EVALUATING THE CARDIO-METABOLIC EFFECTS OF LEVOTHYROXINE AND LIOTHYRONINE COMPARED TO LEVOTHYROXINE WITH PLACEBO IN ATHYREOTIC LOW RISK THYROID CANCER PATIENTS.
     Thyroid. 2023 Sep 19. doi: 10.1089/thy.2023.0135.
     

     >> Share

     
     
133. GUNDA V, Ghosh C, Hu J, Zhang L, et al
     Combination BRAFV600E inhibition with the multitargeting tyrosine kinase inhibitor axitinib shows additive anticancer activity in BRAFV600E-mutant anaplastic thyroid cancer.
     Thyroid. 2023 Sep 7. doi: 10.1089/thy.2023.0201.
     

     >> Share

     
     
134. FAGIN JA, Nikiforov YE
     Progress in Thyroid Cancer Genomics: A 40-Year Journey.
     Thyroid. 2023 Sep 4. doi: 10.1089/thy.2023.0045.
     

     >> Share

     
     August 2023
135. SINCLAIR CF, Baek JH, Hands KE, Hodak SP, et al
     General principles for the safe performance, training and adoption of ablation techniques for benign thyroid nodules: An American Thyroid Association Statement.
     Thyroid. 2023 Aug 29. doi: 10.1089/thy.2023.0281.
     

     >> Share

     
     
136. ROSS DS
     Response to Yan et al. re "Could Radioactive Iodine be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
     Thyroid. 2023 Aug 25. doi: 10.1089/thy.2023.0423.
     

     >> Share

     
     
137. TUTTLE RM MD
     Is there a role for levothyroxine therapy in euthyroid patients on active surveillance for papillary microcarcinomas?
     Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0424.
     

     >> Share

     
     
138. SALAS-LUCIA F, Liao XH, Jiang H, Dumitrescu AM, et al
     The Relationship between Fetal THRB Genotype and Maternal Thyroid Function.
     Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0236.
     

     >> Share

     
     
139. BANG JI, Park S, Kim K, Seo Y, et al
     The Diagnostic Value of F-18 FDG PET/CT in Differentiated Thyroid Cancer Patients with Elevated Thyroglobulin/Thyroglobulin Antibody Levels and Negative Iodine Scintigraphy: A Systematic Review and Meta-analysis.
     Thyroid. 2023 Aug 19. doi: 10.1089/thy.2023.0264.
     

     >> Share

     
     
140. YAN S, Li X, Yan B
     Letter to the Editor: Could Radioactive Iodine Be a Preferred Therapy for Graves' Hyperthyroidism Patients with Large Goiters? A Viewpoint from China.
     Thyroid. 2023 Aug 18. doi: 10.1089/thy.2023.0332.
     

     >> Share

     
     
141. WADSLEY J, Ainsworth G, Coulson AB, Garcez K, et al
     Results of the SEL-I-METRY phase II trial on resensitisation of advanced iodine refractory differentiated thyroid cancer to radioiodine therapy.
     Thyroid. 2023 Aug 11. doi: 10.1089/thy.2022.0707.
     

     >> Share

     
     July 2023
142. DE LEO S, Trevisan M, Re Sarto GV, Moneta C, et al
     TUMOR LYSIS SYNDROME DURING SELPERCATINIB TREATMENT IN A PATIENT WITH MEDULLARY THYROID CANCER.
     Thyroid. 2023 Jul 18. doi: 10.1089/thy.2023.0214.
     

     >> Share

     
     
143. SINGER S, Al-Ibraheem A, Pinto M, Iakovou I, et al
     International phase IV field study for the reliability and validity of the European Organisation for Research and Treatment of Cancer Thyroid Cancer Module EORTC QLQ-THY34.
     Thyroid. 2023 Jul 14. doi: 10.1089/thy.2023.0221.
     

     >> Share

     
     
144. ALI SZ, Baloch ZW, Cochand-Priollet B, Schmitt FC, et al
     The 2023 Bethesda System for Reporting Thyroid Cytopathology.
     Thyroid. 2023 Jul 8. doi: 10.1089/thy.2023.0141.
     

     >> Share

     
     June 2023
145. MARCZYK VR, Recamonde-Mendoza M, Maia AL, Goemann IM, et al
     Classification of Thyroid Tumors Based on DNA Methylation Patterns.
     Thyroid. 2023 Jun 30. doi: 10.1089/thy.2023.0074.
     

     >> Share

     
     
146. LEBOULLEUX S, Benisvy D, Taieb D, Attard M, et al
     MERAIODE: A Phase II Redifferentiation Trial with Trametinib and 131I in Metastatic Radioactive Iodine Refractory RAS Mutated Differentiated thyroid Cancer.
     Thyroid. 2023 Jun 23. doi: 10.1089/thy.2023.0240.
     

     >> Share

     
     
147. O'NEILL C, Carlson M, Rowe C, Fradgley E, et al
     Hearing the voices of Australian thyroid cancer survivors: qualitative thematic analysis of semi-structured interviews identifies unmet support needs.
     Thyroid. 2023 Jun 19. doi: 10.1089/thy.2023.0080.
     

     >> Share

     
     
148. YAMAMOTO M, Miyauchi A, Ito Y, Fujishima M, et al
     Active Surveillance Outcomes of Patients with Low-risk Papillary Thyroid Microcarcinoma According to Levothyroxine Treatment Status.
     Thyroid. 2023 Jun 13. doi: 10.1089/thy.2023.0046.
     

     >> Share

     
     
149. BAUDIN C, Bressand A, Buffet C, Menegaux F, et al
     Dysfunction of the salivary and lacrimal glands after radioiodine therapy for thyroid cancer: Results of the START study after 6-months of follow-up.
     Thyroid. 2023 Jun 10. doi: 10.1089/thy.2023.0090.
     

     >> Share

     
     

Free Medical Abstracts
Privacy Policy
Sponsors
Share